Lifeboat Foundation

#OopsMyBad #Busted 🤔

Yes you read this right. The WHO criticized a drug and used a reference that was neither peer reviewed or published 🙄…Then they removed it as if no one would notice.

The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from dying, according to results from a long-awaited clinical trial conducted in China. Gilead, however, said the data suggest a “potential benefit.”

Continue reading “Data on Gilead’s remdesivir show no benefit for coronavirus patients” »

Eric klein.

If you followed the world of pop-culture or tech for some time now, then you know that advances in artificial intelligence are heating up. In reality, AI has been the talk of mainstream pop-culture and sci-fi since the first Terminator movie came out in 1984. These movies present an example of something called “Artificial General Intelligence.” So how close are we to that?

Continue reading “How Close We Are to Fully Self-Sufficient Artificial Intelligence” »

Airports, airplanes, and passengers will be squeaky clean.

Xenex Disinfection Services found out today its ultraviolet light technology is 99.9 percent effective in eradicating the virus, according to the Texas Biomedical Research Center.

“This is what the world has been looking for„” says Xenex CEO Morris Miller, “to make sure there’s a device that can actually kill the real virus.”

Xenex robots cost $125,000 and are now being ordered by hospitals, hotels, airlines and even the Governor of Texas.

Continue reading “Xenex robots get stamp of approval for COVID-19 elimination” »

The service is seeking information from industry on how fast development and production can go.

Alzheimer’s disease is the sixth leading cause of death in the United States, affecting one in 10 people over the age of 65. Scientists are engineering nanodevices to disrupt processes in the brain that lead to the disease.

People who are affected by Alzheimer’s disease have a specific type of plaque, made of self-assembled molecules called β-amyloid (Aβ) peptides, that build up in the brain over time. This buildup is thought to contribute to loss of neural connectivity and cell death. Researchers are studying ways to prevent the peptides from forming these dangerous plaques in order to halt development of Alzheimer’s disease in the brain.

In a multidisciplinary study, scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory, along with collaborators from the Korean Institute of Science and Technology (KIST) and the Korea Advanced Institute of Science and Technology (KAIST), have developed an approach to prevent plaque formation by engineering a nano-sized device that captures the dangerous peptides before they can self-assemble.

“Most of the vendors have a plan to have a pilot as well as autonomous operations,” he added.

“Since we have put our hand up and said, ‘We want to accelerate this market so that it’s dual-use, the military wants to buy the exact same vehicle that would be available domestically,’ companies have shared with us privately that they have seen the amount of investment given by venture capitalists go up,” Roper said. “And they expect that that will continue the further we go through the door on competition.”

The Air Force plans to request funding for flying car research in the fiscal 2022 budget request, in addition to the research funding the service already set aside for the experiment, he said.

For decades, no one could figure out how to actually build them.

Why not both?